Filter
259
Text search:
drug
manufacturing
Featured
Recommendations
24
New Publications
54
Language
Document type
No document type
107
Studies & Reports
59
Guidelines
50
Strategic & Response Plan
17
Manuals
13
Fact sheets
6
Situation Updates
3
Resource Platforms
2
Training Material
1
Brochures
1
Countries / Regions
Ghana
14
Global
13
Kenya
12
India
8
Ethiopia
7
Uganda
6
Zimbabwe
6
South Africa
6
Zambia
5
Tanzania
5
Botswana
5
Western and Central Europe
5
Nigeria
4
Malawi
4
South–East Asia Region
4
Africa
4
Philippines
3
Nepal
3
Eastern Europe
3
Sierra Leone
2
Senegal
2
Rwanda
2
Sudan
2
Latin America and the Carribbean
2
Congo, Democratic Republic of
1
Cameroon
1
Pakistan
1
Syria
1
Cambodia
1
Indonesia
1
Bangladesh
1
Mozambique
1
Ukraine
1
Lesotho
1
Asia
1
Tajikistan
1
Russia
1
Moldova
1
Uzbekistan
1
Vietnam
1
Turkmenistan
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
100
Clinical Guidelines
17
Pharmacy & Technologies
14
Key Resources
10
Public Health
8
Women & Child Health
3
Capacity Building
2
Toolboxes
AMR
31
COVID-19
30
Pharmacy
28
HIV
18
TB
18
Mental Health
12
Planetary Health
10
Malaria
5
NTDs
4
NCDs
4
Ebola & Marburg
3
Conflict
3
Rapid Response
3
Specific Hazards
3
Global Health Education
3
Caregiver
3
Health Financing Toolbox
3
Natural Hazards
2
2.0 Rapid Response
2
Disability
1
Cholera
1
Polio
1
Refugee
1
Essential Medicines are those that satisfy the priority health care needs of the population. They are selected with due regard to public health relevance, evidence on efficacy, safety and comparative cost-effectiveness. This edition of the Essential Medicines List (EML) 2017 for Ghana has been deriv
...
SOP- Quality Assurance of Malaria Diagnostic Tests
This policy brief aims to provide a review of the current progress on implementing the Malawi national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing a
...
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f
...
The National Action Plan (NAP) has been developed based on the model recommended in the global Action Plan. Local data on on-going interventions were collected from technical informants in the various areas of work. These were analysed using the policy framework provided by the AMR policy document.
...
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread, severe illness and death.1 AMR in recent years has
...
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems’ ability to prov
...
The purpose of this publication is to to provide a practical, stepwise approach to the implementation of the national action plans on AMR within the human health sector; and to provide a process and collation of existing WHO tools to prioritize, cost, implement, monitor and evaluate national action
...
